Retatrutide represents a breakthrough in metabolic research as the first peptide to simultaneously target:

• GLP-1 receptors – Enhancing insulin secretion and β-cell preservation
• GIP receptors – Modulating adipocyte function and nutrient partitioning
• Glucagon receptors – Stimulating hepatic glucose production and energy expenditure

This 10mg nasal spray (50 precisely calibrated doses) enables researchers to:

• Investigate synergistic effects on metabolic parameters
• Conduct long-term studies with non-invasive administration
• Maintain ±5% dose consistency across research protocols
• Study CNS-mediated metabolic effects via nasal-blood-brain barrier pathway

Storage and Handling Protocol

• Optimal Storage: Stable at 20-25°C for 18 months; protect from humidity
• Sterile Procedures: Requires biosafety cabinet handling

Research Administration

• Precision Delivery: 200μg per spray (±3% variance) validated by LC-MS
• Protocol Design: Ideal for q24h dosing in 12-week metabolic studies